Ibrutinib, a BTK inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity in allergic cancer pa... by Regan, Jennifer A., MD, PhD, Petrich, Adam M., MD, Dispenza, Melanie C., MD, PhD, Ma, Shuo, MD, PhD, Gordon, Leo I., MD, Bochner, Bruce S., MD, FAAAAI

Get full text

Ibrutinib, a BTK inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity by Regan, Jennifer A., MD, PhD, Cao, Yun, Dispenza, Melanie C., MD, PhD, Ma, Shuo, MD, PhD, Gordon, Leo I., MD, Petrich, Adam M., MD, Bochner, Bruce S., MD

Get full text